γδ T cells suppress Plasmodium falciparum blood-stage infection by direct killing and phagocytosis.


Journal

Nature immunology
ISSN: 1529-2916
Titre abrégé: Nat Immunol
Pays: United States
ID NLM: 100941354

Informations de publication

Date de publication:
03 2021
Historique:
received: 20 02 2020
accepted: 23 11 2020
pubmed: 13 1 2021
medline: 27 4 2021
entrez: 12 1 2021
Statut: ppublish

Résumé

Activated Vγ9Vδ2 (γδ2) T lymphocytes that sense parasite-produced phosphoantigens are expanded in Plasmodium falciparum-infected patients. Although previous studies suggested that γδ2 T cells help control erythrocytic malaria, whether γδ2 T cells recognize infected red blood cells (iRBCs) was uncertain. Here we show that iRBCs stained for the phosphoantigen sensor butyrophilin 3A1 (BTN3A1). γδ2 T cells formed immune synapses and lysed iRBCs in a contact, phosphoantigen, BTN3A1 and degranulation-dependent manner, killing intracellular parasites. Granulysin released into the synapse lysed iRBCs and delivered death-inducing granzymes to the parasite. All intra-erythrocytic parasites were susceptible, but schizonts were most sensitive. A second protective γδ2 T cell mechanism was identified. In the presence of patient serum, γδ2 T cells phagocytosed and degraded opsonized iRBCs in a CD16-dependent manner, decreasing parasite multiplication. Thus, γδ2 T cells have two ways to control blood-stage malaria-γδ T cell antigen receptor (TCR)-mediated degranulation and phagocytosis of antibody-coated iRBCs.

Identifiants

pubmed: 33432229
doi: 10.1038/s41590-020-00847-4
pii: 10.1038/s41590-020-00847-4
pmc: PMC7906917
mid: NIHMS1649439
doi:

Substances chimiques

Antigens, CD 0
Antigens, Differentiation, T-Lymphocyte 0
Antigens, Protozoan 0
BTN2A1 protein, human 0
BTN3A1 protein, human 0
Butyrophilins 0
GNLY protein, human 0
GZMB protein, human EC 3.4.21.-
Granzymes EC 3.4.21.-

Types de publication

Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

347-357

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI116577
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI131632
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI089681
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI150546
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI145941
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS098747
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Junqueira, C. et al. Cytotoxic CD
pubmed: 30038217 pmcid: 6129205 doi: 10.1038/s41591-018-0117-4
Silvestre, D., Kourilsky, F. M., Nicolai, M. G. & Levy, J. P. Presence of HLA antigens on human reticulocytes as demonstrated by electron microscopy. Nature 228, 67–68 (1970).
pubmed: 5460343 doi: 10.1038/228067a0
Worku, S. et al. Lymphocyte activation and subset redistribution in the peripheral blood in acute malaria illness: distinct γδ
pubmed: 9097908 pmcid: 1904634 doi: 10.1046/j.1365-2249.1997.d01-981.x
Troye-Blomberg, M. et al. Human γδ T cells that inhibit the in vitro growth of the asexual blood stages of the Plasmodium falciparum parasite express cytolytic and proinflammatory molecules. Scand. J. Immunol. 50, 642–650 (1999).
pubmed: 10607313 doi: 10.1046/j.1365-3083.1999.00647.x
Ramsey, J. M. et al. Plasmodium falciparum and P. vivax gametocyte-specific exoantigens stimulate proliferation of TCR γδ
pubmed: 12053981
Pichyangkul, S., Saengkrai, P., Yongvanitchit, K., Stewart, A. & Heppner, D. G. Activation of γδ T cells in malaria: interaction of cytokines and a schizont-associated Plasmodium falciparum antigen. J. Infect. Dis. 176, 233–241 (1997).
pubmed: 9207372 doi: 10.1086/514029
Jagannathan, P. et al. Vδ2+ T cell response to malaria correlates with protection from infection but is attenuated with repeated exposure. Sci. Rep. 7, 11487 (2017).
pubmed: 28904345 pmcid: 5597587 doi: 10.1038/s41598-017-10624-3
Farrington, L. A. et al. Frequent malaria drives progressive Vδ2 T-cell loss, dysfunction, and CD16 up-regulation during early childhood. J. Infect. Dis. 213, 1483–1490 (2016).
pubmed: 26667315 doi: 10.1093/infdis/jiv600
Jagannathan, P. et al. Loss and dysfunction of Vδ2
pubmed: 25163477 pmcid: 4198150 doi: 10.1126/scitranslmed.3009793
Farouk, S. E., Mincheva-Nilsson, L., Krensky, A. M., Dieli, F. & Troye-Blomberg, M. γδ T cells inhibit in vitro growth of the asexual blood stages of Plasmodium falciparum by a granule exocytosis-dependent cytotoxic pathway that requires granulysin. Eur. J. Immunol. 34, 2248–2256 (2004).
pubmed: 15259022 doi: 10.1002/eji.200424861
Liu, C. et al. Vγ9Vδ2 T cells proliferate in response to phosphoantigens released from erythrocytes infected with asexual and gametocyte stage Plasmodium falciparum. Cell. Immunol. 334, 11–19 (2018).
pubmed: 30177348 doi: 10.1016/j.cellimm.2018.08.012
Guenot, M. et al. Phosphoantigen burst upon Plasmodium falciparum schizont rupture can distantly activate Vγ9Vδ2 T cells. Infect. Immun. 83, 3816–3824 (2015).
pubmed: 26169273 pmcid: 4567633 doi: 10.1128/IAI.00446-15
Vavassori, S. et al. Butyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ T cells. Nat. Immunol. 14, 908–916 (2013).
pubmed: 23872678 doi: 10.1038/ni.2665
Wang, H. et al. Butyrophilin 3A1 plays an essential role in prenyl pyrophosphate stimulation of human Vγ2Vδ2 T cells. J. Immunol. 191, 1029–1042 (2013).
pubmed: 23833237 doi: 10.4049/jimmunol.1300658
Seder, R. A. et al. Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Science 341, 1359–1365 (2013).
pubmed: 23929949 doi: 10.1126/science.1241800
Mordmuller, B. et al. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Nature 542, 445–449 (2017).
pubmed: 28199305 doi: 10.1038/nature21060
Ishizuka, A. S. et al. Protection against malaria at 1 year and immune correlates following PfSPZ vaccination. Nat. Med. 22, 614–623 (2016).
pubmed: 27158907 doi: 10.1038/nm.4110
Zaidi, I. et al. γδ T cells are required for the induction of sterile immunity during irradiated sporozoite vaccinations. J. Immunol. 199, 3781–3788 (2017).
pubmed: 29079696 pmcid: 5698172 doi: 10.4049/jimmunol.1700314
Costa, G. et al. Control of Plasmodium falciparum erythrocytic cycle: γδ T cells target the red blood cell-invasive merozoites. Blood 118, 6952–6962 (2011).
pubmed: 22045985 doi: 10.1182/blood-2011-08-376111
Dotiwala, F. & Lieberman, J. Granulysin: killer lymphocyte safeguard against microbes. Curr. Opin. Immunol. 60, 19–29 (2019).
pubmed: 31112765 pmcid: 6800608 doi: 10.1016/j.coi.2019.04.013
Wu, Y. et al. Human γδ T cells: a lymphoid lineage cell capable of professional phagocytosis. J. Immunol. 183, 5622–5629 (2009).
pubmed: 19843947 doi: 10.4049/jimmunol.0901772
Himoudi, N. et al. Human γδ T lymphocytes are licensed for professional antigen presentation by interaction with opsonized target cells. J. Immunol. 188, 1708–1716 (2012).
pubmed: 22250090 doi: 10.4049/jimmunol.1102654
Brandes, M., Willimann, K. & Moser, B. Professional antigen-presentation function by human γδ T cells. Science 309, 264–268 (2005).
pubmed: 15933162 doi: 10.1126/science.1110267
Meuter, S., Eberl, M. & Moser, B. Prolonged antigen survival and cytosolic export in cross-presenting human γδ T cells. Proc. Natl Acad. Sci. USA 107, 8730–8735 (2010).
pubmed: 20413723 doi: 10.1073/pnas.1002769107
Howard, J. et al. The antigen-presenting potential of Vγ9Vδ2 T cells during Plasmodium falciparum blood-stage infection. J. Infect. Dis 215, 1569–1579 (2017).
pubmed: 28368498 doi: 10.1093/infdis/jix149
Barisa, M. et al. E. coli promotes human Vγ9Vδ2 T cell transition from cytokine-producing bactericidal effectors to professional phagocytic killers in a TCR-dependent manner. Sci. Rep. 7, 2805 (2017).
pubmed: 28584241 pmcid: 5459831 doi: 10.1038/s41598-017-02886-8
Hsiao, C. H. et al. Synthesis of a phosphoantigen prodrug that potently activates Vγ9Vδa2 T-lymphocytes. Chem. Biol. 21, 945–954 (2014).
pubmed: 25065532 doi: 10.1016/j.chembiol.2014.06.006
Yang, Y. et al. A structural change in butyrophilin upon phosphoantigen binding underlies phosphoantigen-mediated Vγ9Vδ2 T cell activation. Immunity 50, 1043–1053.e5 (2019).
pubmed: 30902636 doi: 10.1016/j.immuni.2019.02.016
Gu, S. et al. Phosphoantigen-induced conformational change of butyrophilin 3A1 (BTN3A1) and its implication on Vγ9Vδ2 T cell activation. Proc. Natl Acad. Sci. USA 114, E7311–E7320 (2017).
pubmed: 28807997 doi: 10.1073/pnas.1707547114
Karunakaran, M. M. et al. Butyrophilin-2A1 directly binds germline-encoded regions of the Vγ9Vδ2 TCR and is essential for phosphoantigen sensing. Immunity 52, 487–498.e6 (2020).
pubmed: 32155411 pmcid: 7083227 doi: 10.1016/j.immuni.2020.02.014
Rigau, M. et al. Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells. Science https://doi.org/10.1126/science.aay5516 (2020).
Dotiwala, F. et al. Killer lymphocytes use granulysin, perforin and granzymes to kill intracellular parasites. Nat. Med. 22, 210–216 (2016).
pubmed: 26752517 pmcid: 7325279 doi: 10.1038/nm.4023
Muto, M., Baghdadi, M., Maekawa, R., Wada, H. & Seino, K. Myeloid molecular characteristics of human γδ T cells support their acquisition of tumor antigen-presenting capacity. Cancer Immunol. Immunother. 64, 941–949 (2015).
pubmed: 25904200 doi: 10.1007/s00262-015-1700-x
Yeh, E. & DeRisi, J. L. Chemical rescue of malaria parasites lacking an apicoplast defines organelle function in blood-stage Plasmodium falciparum. PLoS Biol. 9, e1001138 (2011).
pubmed: 21912516 pmcid: 3166167 doi: 10.1371/journal.pbio.1001138
Kurup, S. P., Butler, N. S. & Harty, J. T. T cell-mediated immunity to malaria. Nat. Rev. Immunol. 19, 457–471 (2019).
pubmed: 30940932 pmcid: 6599480 doi: 10.1038/s41577-019-0158-z
Arora, G. et al. NK cells inhibit Plasmodium falciparum growth in red blood cells via antibody-dependent cellular cytotoxicity. Elife https://doi.org/10.7554/eLife.36806 (2018).
Goodier, M. R., Wolf, A. S. & Riley, E. M. Differentiation and adaptation of natural killer cells for anti-malarial immunity. Immunol. Rev. 293, 25–37 (2020).
pubmed: 31762040 doi: 10.1111/imr.12798
Ravenhill, B. J. et al. Quantitative comparative analysis of human erythrocyte surface proteins between individuals from two genetically distinct populations. Commun. Biol. 2, 350 (2019).
pubmed: 31552303 pmcid: 6754445 doi: 10.1038/s42003-019-0596-y
Bryk, A. H. & Wisniewski, J. R. Quantitative analysis of human red blood cell proteome. J. Proteome Res. 16, 2752–2761 (2017).
pubmed: 28689405 doi: 10.1021/acs.jproteome.7b00025
Barbee, S. D. et al. Skint-1 is a highly specific, unique selecting component for epidermal T cells. Proc. Natl Acad. Sci. USA 108, 3330–3335 (2011).
pubmed: 21300860 doi: 10.1073/pnas.1010890108
Turchinovich, G. & Hayday, A. C. Skint-1 identifies a common molecular mechanism for the development of interferon-γ-secreting versus interleukin-17-secreting γδ T cells. Immunity 35, 59–68 (2011).
pubmed: 21737317 doi: 10.1016/j.immuni.2011.04.018
Gordon, S. Phagocytosis: an immunobiologic process. Immunity 44, 463–475 (2016).
pubmed: 26982354 doi: 10.1016/j.immuni.2016.02.026
Chien, Y. H., Meyer, C. & Bonneville, M. γδ T cells: first line of defense and beyond. Annu. Rev. Immunol. 32, 121–155 (2014).
pubmed: 24387714 doi: 10.1146/annurev-immunol-032713-120216
Das, S. et al. Evolution of two prototypic T cell lineages. Cell Immunol. 296, 87–94 (2015).
pubmed: 25958271 pmcid: 4466127 doi: 10.1016/j.cellimm.2015.04.007
Barry, A. & Hansen, D. Naturally acquired immunity to malaria. Parasitology 143, 125–128 (2016).
pubmed: 26745829 doi: 10.1017/S0031182015001778
Crompton, P. D. et al. Malaria immunity in man and mosquito: insights into unsolved mysteries of a deadly infectious disease. Annu. Rev. Immunol. 32, 157–187 (2014).
pubmed: 24655294 pmcid: 4075043 doi: 10.1146/annurev-immunol-032713-120220
Moebius, J. et al. PD-1 expression on NK cells in malaria-exposed individuals is associated with diminished natural cytotoxicity and enhanced antibody dependent cellular cytotoxicity. Infect. Immun. 88, e00711-19 (2020).
pubmed: 31907195 pmcid: 7035929 doi: 10.1128/IAI.00711-19
Hart, G. T. et al. Adaptive NK cells in people exposed to Plasmodium falciparum correlate with protection from malaria. J. Exp. Med. 216, 1280–1290 (2019).
pubmed: 30979790 pmcid: 6547858 doi: 10.1084/jem.20181681
Hernandez-Castaneda, M. A. et al. γδ T cells kill Plasmodium falciparum in a granzyme- and granulysin-dependent mechanism during the late blood stage. J. Immunol. 204, 1798–1809 (2020).
pubmed: 32066596 pmcid: 7086388 doi: 10.4049/jimmunol.1900725
Stenger, S. et al. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 282, 121–125 (1998).
pubmed: 9756476 doi: 10.1126/science.282.5386.121
Ribaut, C. et al. Concentration and purification by magnetic separation of the erythrocytic stages of all human Plasmodium species. Malar. J. 7, 45 (2008).
pubmed: 18321384 pmcid: 2292734 doi: 10.1186/1475-2875-7-45
Betts, M. R. et al. Sensitive and viable identification of antigen-specific CD8
pubmed: 14580882 doi: 10.1016/S0022-1759(03)00265-5
Thiery, J., Walch, M., Jensen, D. K., Martinvalet, D. & Lieberman, J. Isolation of cytotoxic T cell and NK granules and purification of their effector proteins. Curr. Protoc. Cell Biol. 47, 3.37.1–3.37.29 (2010).
doi: 10.1002/0471143030.cb0337s47

Auteurs

Caroline Junqueira (C)

Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA, USA. caroline.junqueira@fiocruz.br.
Department of Pediatrics, Harvard Medical School, Boston, MA, USA. caroline.junqueira@fiocruz.br.
Instituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, MG, Brazil. caroline.junqueira@fiocruz.br.

Rafael B Polidoro (RB)

Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA, USA.
Department of Pediatrics, Harvard Medical School, Boston, MA, USA.

Guilherme Castro (G)

Instituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, MG, Brazil.
Departamento de Bioquímica e Imunologia, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.

Sabrina Absalon (S)

Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA.
Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, IN, USA.

Zhitao Liang (Z)

Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA, USA.
Department of Pediatrics, Harvard Medical School, Boston, MA, USA.

Sumit Sen Santara (S)

Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA, USA.
Department of Pediatrics, Harvard Medical School, Boston, MA, USA.

Ângela Crespo (Â)

Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA, USA.
Department of Pediatrics, Harvard Medical School, Boston, MA, USA.

Dhelio B Pereira (DB)

Centro de Pesquisa em Medicina Tropical de Rondônia, Porto Velho, RO, Brazil.

Ricardo T Gazzinelli (RT)

Instituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, MG, Brazil.
Departamento de Bioquímica e Imunologia, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA.
Plataforma de Medicina Translacional, Fundação Oswaldo Cruz, Ribeirão Preto, SP, Brazil.

Jeffrey D Dvorin (JD)

Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, USA.

Judy Lieberman (J)

Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA, USA. judy.lieberman@childrens.harvard.edu.
Department of Pediatrics, Harvard Medical School, Boston, MA, USA. judy.lieberman@childrens.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH